4.7 Article

Redirecting the JAK-STAT signal blocks the SARS-CoV-2 replication

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Tuning protein half-life in mouse using sequence defined biopolymers functionalized with lipids

Koen Vanderschuren et al.

Summary: The use of biologics in disease treatment has been increasing due to their specificity, low toxicity, and limited side effects. However, peptide- and protein-based drugs have limitations in terms of short half-lives and immunogenicity. To address these challenges, researchers have used a genomically recoded organism to produce synthetic biopolymers with programmable binding affinity and tunable half-lives. This work provides a proof of concept for extending and regulating the half-life of protein or peptide therapeutics.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Biochemistry & Molecular Biology

Incorporation of Halogenated Amino Acids into Antibody Fragments at Multiple Specific Sites Enhances Antigen Binding

Akiko Hayashi et al.

Summary: The study shows that introducing halogenated tyrosines into antibodies can significantly enhance antigen binding, with a tenfold increase in affinity observed when specific tyrosines are replaced at multiple sites. Additionally, even adding chlorination in regions far from the binding interface can greatly improve affinity, up to 17-fold.

CHEMBIOCHEM (2021)

Article Biochemistry & Molecular Biology

Genetically encoded dihydroxyphenylalanine coupled with tyrosinase for strain promoted labeling

Augustine George et al.

Summary: Genetic code engineering is used to modify proteins for enhanced biological availability, with the addition of 3,4-dihydroxy-L-phenylalanine through tyrosinase catalysis. This method allows for selective cell labeling and improved sensitivity for protein-based fluorescence labeling.

BIOORGANIC & MEDICINAL CHEMISTRY (2021)

Article Biotechnology & Applied Microbiology

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2

Tesia Bobrowski et al.

Summary: This study identified 16 synergistic drug combinations against SARS-CoV-2, with nitazoxanide combined with remdesivir, amodiaquine, or umifenovir showing significant synergy. However, the combination of remdesivir with lysosomotropic drugs like hydroxychloroquine exhibited strong antagonism. The results highlight the potential of drug repurposing and preclinical testing of drug combinations for treating COVID-19.

MOLECULAR THERAPY (2021)

Article Engineering, Biomedical

Self-Assembly and Mechanical Properties of Engineered Protein Based Multifunctional Nanofiber for Accelerated Wound Healing

George Augustine et al.

Summary: This study presents a novel approach for preparing tunable multifunctional biomaterials through the combination of synthetic biology and material chemistry. The genetically encoded catechol moiety in a nanofiber mat promotes self-assembly and wet adhesion property of the protein, and is further utilized for the controlled release of boric acid to accelerate wound healing. The presence of 3,4-dihydroxyphenylalanine in the nanofiber mat acts as a stimulus to trigger cell proliferation, migration, and vascularization, contributing to the acceleration of wound healing. Various spectroscopic methods confirm the structural integrity, antioxidant property, and controlled release of boric acid, while microscopy techniques reveal the 3D architecture of the nanofiber mat favorable for fibroblast growth, endothelial cell attachment, and tube formation, supporting its role as a desirable wound-healing material. Animal studies demonstrate that the multifunctional biomaterial significantly improves re-epithelialization and accelerates wound closure in a murine wound healing model.

ADVANCED HEALTHCARE MATERIALS (2021)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Proteins Exploit Host's Genetic and Epigenetic Mediators for the Annexation of Key Host Signaling Pathways

Md. Abdullah-Al-Kamran Khan et al.

Summary: The virus can enhance its survival by manipulating key signaling pathways in host cells, leading to more complex host responses to the virus, which may result in pathological abnormalities in the lungs and other organs, as well as an increased risk of infection for patients with comorbidities.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Critical Care Medicine

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip D. Monk et al.

Summary: The study evaluated the efficacy and safety of using interferon beta-1a to treat COVID-19, with results showing that patients who received treatment had higher and faster recovery rates, providing potential evidence for further clinical trials.

LANCET RESPIRATORY MEDICINE (2021)

Review Biochemistry & Molecular Biology

Type I and III interferon responses in SARS-CoV-2 infection

You-Me Kim et al.

Summary: Researchers have reviewed how SARS-CoV-2 manipulates the immune system by inhibiting host IFN responses, leading to delayed and exaggerated inflammation, which contributes to the severity of COVID-19. Further investigations are needed to better understand the mechanisms behind these immune system dysfunctions caused by the virus.

EXPERIMENTAL AND MOLECULAR MEDICINE (2021)

Article Virology

SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway

Da-Yuan Chen et al.

Summary: SARS-CoV-2 can infect multiple organs in the human body and evade host antiviral immunity by suppressing interferon signaling. Targeting viral mediators of immune evasion may help block virus replication.

JOURNAL OF VIROLOGY (2021)

Article Clinical Neurology

The role of interferons type I, II and III in myositis: A review

Lois Bolko et al.

Summary: The classification of idiopathic inflammatory myopathies is based on clinical, serological, and histological criteria. The identification of myositis-specific antibodies has helped to define more homogeneous groups of myositis into four dominant subsets, each with distinct pathophysiological mechanisms. Additionally, interferon pathways have been identified as key players in the pathophysiology of myositis, with different types of interferons playing specific roles in each subset.

BRAIN PATHOLOGY (2021)

Review Biochemistry & Molecular Biology

Aggregation of protein therapeutics enhances their immunogenicity: causes and mitigation strategies

Mimmi L. E. Lundahl et al.

Summary: This review discusses the immune activation mechanisms triggered by protein aggregates and the physicochemical properties of aggregates, as well as factors influencing protein stability and aggregation. It advocates for an innovative and multidisciplinary approach in future drug development to avoid immunogenic aggregation.

RSC CHEMICAL BIOLOGY (2021)

Review Immunology

Pathogenicity and virulence of hepatitis A virus

Rosa M. Pinto et al.

Summary: Hepatitis A is an acute liver infection that is mostly asymptomatic in children but becomes more severe with age. While most patients recover completely, some may experience prolonged, relapsed, or fulminant forms. The severity of the infection is believed to be determined by host factors such as immunological status, age, and underlying liver diseases, with possible contributions from virus traits.

VIRULENCE (2021)

Review Urology & Nephrology

Evolution of SARS-CoV-2: Review of Mutations, Role of the Host Immune System

Helene Banoun

Summary: The article emphasizes on the mutations that have occurred in the virus since the beginning of the COVID-19 pandemic, as well as the cross-reactivity between common cold coronaviruses and SARS-CoV-2 in a majority of the population. Important evolutionary mutations have emerged in genes encoding proteins that interact with the host immune system, such as viral polymerase. The relationship between cross-reactivity and viral mutations may partly explain the evolution of the pandemic until the summer of 2020.

NEPHRON (2021)

Review Microbiology

Coronavirus biology and replication: implications for SARS-CoV-2

Philip V'kovski et al.

Summary: This review discusses key aspects of coronavirus biology and their implications for SARS-CoV-2 infections, treatment, and prevention strategies. Understanding virus-host interactions at the molecular level is crucial for developing effective intervention strategies. Summarizing the discoveries of SARS-CoV-2 infection and comparing it with other coronaviruses will support future preparedness and combat strategies.

NATURE REVIEWS MICROBIOLOGY (2021)

Editorial Material Medicine, Research & Experimental

COVID-19: lambda interferon against viral load and hyperinflammation

Evangelos Andreakos et al.

EMBO MOLECULAR MEDICINE (2020)

Editorial Material Biochemistry & Molecular Biology

Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear

Nathan D. Grubaugh et al.

Article Infectious Diseases

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies

Atul Sharma et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

Article Pharmacology & Pharmacy

Microscale Thermophoresis as a Screening Tool to Predict Melanin Binding of Drugs

Laura Hellinen et al.

PHARMACEUTICS (2020)

Article Multidisciplinary Sciences

Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and interactions

Yingjie Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Pharmacology & Pharmacy

Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19

Rudra P. Saha et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Nanoscience & Nanotechnology

Enhanced Cellular Uptake and Sustained Transdermal Delivery of Collagen for Skin Regeneration

Suryalakshmi Pandurangan et al.

ACS APPLIED BIO MATERIALS (2020)

Review Biochemistry & Molecular Biology

Using genetically incorporated unnatural amino acids to control protein functions in mammalian cells

Alexander R. Nodling et al.

SINGLE CELL BIOLOGY (2019)

Review Biochemistry & Molecular Biology

A Comprehensive Review on Current Advances in Peptide Drug Development and Design

Andy Chi-Lung Lee et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Biochemical Research Methods

Genetic Incorporation of Noncanonical Amino Acids Using Two Mutually Orthogonal Quadruplet Codons

Erome Daniel Hankore et al.

ACS SYNTHETIC BIOLOGY (2019)

Review Biotechnology & Applied Microbiology

Therapeutic applications of genetic code expansion

Yujia Huang et al.

SYNTHETIC AND SYSTEMS BIOTECHNOLOGY (2018)

Article Chemistry, Multidisciplinary

Next Generation Designed Protein as a Photosensitizer for Biophotovoltaics Prepared by Expanding the Genetic Code

K. Deepankumar et al.

ACS SUSTAINABLE CHEMISTRY & ENGINEERING (2017)

Article Immunology

Development of a high-throughput colorimetric Zika virus infection assay

Janis A. Mueller et al.

MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2017)

Article Multidisciplinary Sciences

Interferon-beta represses cancer stem cell properties in triple-negative breast cancer

Mary R. Doherty et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Biology

Factors affecting the physical stability (aggregation) of peptide therapeutics

Karolina L. Zapadka et al.

INTERFACE FOCUS (2017)

Review Immunology

The urgent need to recover MHC class I in cancers for effective immunotherapy

Federico Garrido et al.

CURRENT OPINION IN IMMUNOLOGY (2016)

Article Biochemistry & Molecular Biology

The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses

Katarzyna Blaszczyk et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2016)

Article Multidisciplinary Sciences

Regulation of protein-ligand binding affinity by hydrogen bond pairing

Deliang Chen et al.

SCIENCE ADVANCES (2016)

Article Biochemistry & Molecular Biology

STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1

Katarzyna Blaszczyk et al.

BIOCHEMICAL JOURNAL (2015)

Review Pharmacology & Pharmacy

Peptide therapeutics: current status and future directions

Keld Fosgerau et al.

DRUG DISCOVERY TODAY (2015)

Review Immunology

Interferon-Stimulated Genes: A Complex Web of Host Defenses

William M. Schneider et al.

ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)

Review Immunology

Regulation of type I interferon responses

Lionel B. Ivashkiv et al.

NATURE REVIEWS IMMUNOLOGY (2014)

Article Immunology

Variability in detection and quantification of interferon β-1b-induced neutralizing antibodies

Hans-Peter Hartung et al.

JOURNAL OF NEUROINFLAMMATION (2012)

Review Biochemistry & Molecular Biology

Pattern Recognition Receptors and Inflammation

Osamu Takeuchi et al.

Article Chemistry, Physical

Synthetic Biology of Protein Folding

Luis Moroder et al.

CHEMPHYSCHEM (2010)

Review Biochemistry & Molecular Biology

On the Role of Aggregates in the Immunogenicity of Recombinant Human Interferon Beta in Patients with Multiple Sclerosis

Miranda M. C. van Beers et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2010)

Review Chemistry, Multidisciplinary

Stability of Protein Pharmaceuticals: An Update

Mark Cornell Manning et al.

PHARMACEUTICAL RESEARCH (2010)

Review Pharmacology & Pharmacy

Immunological mechanism underlying the immune response to recombinant human protein therapeutics

Melody Sauerborn et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2010)

Review Biochemistry & Molecular Biology

Expanding the Genetic Code for Biological Studies

Qian Wang et al.

CHEMISTRY & BIOLOGY (2009)

Review Microbiology

Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses

Trine H. Mogensen

CLINICAL MICROBIOLOGY REVIEWS (2009)

Article Virology

Molecular diagnosis and analysis of Chikungunya virus

Carolyn J. Edwards et al.

JOURNAL OF CLINICAL VIROLOGY (2007)

Article Clinical Neurology

Interferon-beta - Mechanism of action and dosing issues

Clyde E. Markowitz

NEUROLOGY (2007)

Article Immunology

A critical function for type I interferons in cancer immunoediting

GP Dunn et al.

NATURE IMMUNOLOGY (2005)